Related Experiment Video

Updated: Jun 5, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

Autophagy modulation for cancer therapy

Zhineng J Yang1, Cheng E Chee, Shengbing Huang

  • 1Mayo Clinic and Mayo Cancer Center, 200 First Street SW, Rochester, MN 55905, USA.

Cancer Biology & Therapy
|January 26, 2011
PubMed

Insights

Autophagy, a cellular process, plays a dual role in cancer, acting as a tumor suppressor but also promoting survival and resistance. Inhibiting autophagy enhances cancer therapy effectiveness.

Area of Science:

  • Cell Biology
  • Cancer Biology
  • Molecular Biology

Background:

  • Autophagy is a fundamental cellular process for degrading damaged components, crucial for maintaining genomic stability and cell survival.
  • Dysregulation of autophagy is implicated in cancer development, with evidence suggesting a tumor suppressor role for the autophagy gene Beclin 1.
  • Autophagy contributes to cancer progression, dormancy, and resistance to therapy by providing stress tolerance and promoting cell viability.

Purpose of the Study:

  • To explore the multifaceted role of autophagy in cancer, including its implications in tumor suppression, dormancy, and therapeutic resistance.
  • To investigate the potential of modulating autophagy as a novel strategy for cancer prevention and treatment.
  • To identify autophagy as a potential target for anticancer drug discovery.

Main Methods:

  • Review of existing literature on autophagy's role in cancer biology.
  • Analysis of studies involving gene knockout models (e.g., Beclin 1 +/- mice) to assess autophagy's tumor suppressor function.
  • Examination of preclinical and clinical data on the impact of autophagy modulation (genetic or pharmacological) on anticancer drug efficacy.

Main Results:

  • Autophagy acts as a tumor suppressor, as indicated by tumor predisposition in Beclin 1 deficient mice.
  • Autophagy promotes cancer cell survival under stress, contributing to tumor dormancy, progression, and resistance to chemotherapy.
  • Inhibition of pro-survival autophagy enhances the efficacy of anticancer drugs, leading to increased cancer cell death.

Conclusions:

  • Autophagy exhibits a complex, context-dependent role in cancer, acting as both a tumor suppressor and a pro-survival mechanism.
  • Targeting autophagy, particularly inhibiting cytoprotective pathways, represents a promising therapeutic strategy to enhance anticancer treatments.
  • Further research is essential to optimize strategies for modulating autophagy in cancer therapy and drug development.

More Related Videos

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase09:51

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase

Published on: June 30, 2023

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry11:39

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry

Published on: July 21, 2017

Related Concept Videos

Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...